Gene · 7185
Papers2,530
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,530
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis. | Commun Biol | 2022 | 36344664 | PubTator, text mining | PubMed |
| Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy. | Front Pharmacol | 2022 | 36339601 | PubTator, text mining | PubMed |
| Major pathways involved in macrophage polarization in cancer. | Front Immunol | 2022 | 36325334 | PubTator, text mining | PubMed |
| Lentivirus-mediated short hairpin RNA interference of CENPK inhibits growth of colorectal cancer cells with overexpression of Cullin 4A. | World J Gastroenterol | 2022 | 36312839 | PubTator, text mining | PubMed |
| Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas. | Cancers (Basel) | 2022 | 36291756 | PubTator, text mining | PubMed |
| TRAF3/p38-JNK Signalling Crosstalk with Intracellular-TRAIL/Caspase-10-Induced Apoptosis Accelerates ROS-Driven Cancer Cell-Specific Death by CD40. | Cells | 2022 | 36291141 | PubTator, text mining | PubMed |
| Depicting the Implication of miR-378a in Cancers. | Technol Cancer Res Treat | 2022 | 36285472 | PubTator, text mining | PubMed |
| Role of CD40(L)-TRAF signaling in inflammation and resolution-a double-edged sword. | Front Pharmacol | 2022 | 36267276 | PubTator, text mining | PubMed |
| Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement. | Mater Today Bio | 2022 | 36267139 | PubTator, text mining | PubMed |
| Identification pyroptosis-related gene signature to predict prognosis and associated regulation axis in colon cancer. | Front Pharmacol | 2022 | 36249755 | PubTator, text mining | PubMed |
| Analysis of chromatin data supports a role for CD14+ monocytes/macrophages in mediating genetic risk for juvenile idiopathic arthritis. | Front Immunol | 2022 | 36248892 | PubTator, text mining | PubMed |
| Knockdown of circ_0038467 alleviates lipopolysaccharides-induced 16HBE cell injury by regulating the miR-545-3p/TRAF1 axis in neonatal pneumonia. | Microb Pathog | 2022 | 36216207 | PubTator, text mining | PubMed |
| Functional inference of gene regulation using single-cell multi-omics. | Cell Genom | 2022 | 36204155 | PubTator, text mining | PubMed |
| CD8+ T cell-associated genes MS4A1 and TNFRSF17 are prognostic markers and inhibit the progression of colon cancer. | Front Oncol | 2022 | 36203424 | PubTator, text mining | PubMed |
| The role of macrophage subtypes and exosomes in immunomodulation. | Cell Mol Biol Lett | 2022 | 36192691 | PubTator, text mining | PubMed |
| Triptolide attenuates inhibition of ankylosing spondylitis-derived mesenchymal stem cells on the osteoclastogenesis through modulating exosomal transfer of circ-0110634. | J Orthop Translat | 2022 | 36185580 | PubTator, text mining | PubMed |
| Novel biochemical, structural, and systems insights into inflammatory signaling revealed by contextual interaction proteomics. | Proc Natl Acad Sci U S A | 2022 | 36179048 | PubTator, text mining | PubMed |
| Multiomics analysis reveals the mechanical stress-dependent changes in trabecular meshwork cytoskeletal-extracellular matrix interactions. | Front Cell Dev Biol | 2022 | 36176278 | PubTator, text mining | PubMed |
| E3 ubiquitin ligase NEDD4L negatively regulates inflammation by promoting ubiquitination of MEKK2. | EMBO Rep | 2022 | 36161689 | PubTator, text mining | PubMed |
| Prodigious therapeutic effects of combining mesenchymal stem cells with magnetic nanoparticles. | World J Stem Cells | 2022 | 36157526 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7185/papers?page=16